BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24359226)

  • 1. Correlation between the methylation of SULF2 and WRN promoter and the irinotecan chemosensitivity in gastric cancer.
    Wang L; Xie L; Wang J; Shen J; Liu B
    BMC Gastroenterol; 2013 Dec; 13():173. PubMed ID: 24359226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation between the methylation of SULF2 and WRN promoter and chemosensitivity to irinotecan in gastric cancer].
    Wang L; Shen J; Meng LJ; Fan WF; Wang J; Liu BR
    Zhonghua Zhong Liu Za Zhi; 2013 Jun; 35(6):418-22. PubMed ID: 24119900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SULF2 methylation is associated with in vitro cisplatin sensitivity and clinical efficacy for gastric cancer patients treated with a modified FOLFOX regimen.
    Shen J; Wei J; Wang H; Yang Y; Yue G; Wang L; Yu L; Xie L; Sun X; Bian X; Zou Z; Qian X; Guan W; Liu B
    PLoS One; 2013; 8(10):e75564. PubMed ID: 24124496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of epigenetic inactivation of the WRN gene with anticancer drug sensitivity in cervical cancer cells.
    Masuda K; Banno K; Yanokura M; Tsuji K; Kobayashi Y; Kisu I; Ueki A; Yamagami W; Nomura H; Tominaga E; Susumu N; Aoki D
    Oncol Rep; 2012 Oct; 28(4):1146-52. PubMed ID: 22797812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A three-gene signature as potential predictive biomarker for irinotecan sensitivity in gastric cancer.
    Shen J; Wei J; Wang H; Yue G; Yu L; Yang Y; Xie L; Zou Z; Qian X; Ding Y; Guan W; Liu B
    J Transl Med; 2013 Mar; 11():73. PubMed ID: 23517622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SULF2 methylation is prognostic for lung cancer survival and increases sensitivity to topoisomerase-I inhibitors via induction of ISG15.
    Tessema M; Yingling CM; Thomas CL; Klinge DM; Bernauer AM; Liu Y; Dacic S; Siegfried JM; Dahlberg SE; Schiller JH; Belinsky SA
    Oncogene; 2012 Sep; 31(37):4107-16. PubMed ID: 22158045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WRN Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based Therapy.
    Bosch LJ; Luo Y; Lao VV; Snaebjornsson P; Trooskens G; Vlassenbroeck I; Mongera S; Tang W; Welcsh P; Herman JG; Koopman M; Nagtegaal ID; Punt CJ; van Criekinge W; Meijer GA; Monnat RJ; Carvalho B; Grady WM
    Clin Cancer Res; 2016 Sep; 22(18):4612-22. PubMed ID: 27121793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased chemotherapeutic activity of camptothecin in cancer cells by siRNA-induced silencing of WRN helicase.
    Futami K; Takagi M; Shimamoto A; Sugimoto M; Furuichi Y
    Biol Pharm Bull; 2007 Oct; 30(10):1958-61. PubMed ID: 17917271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer.
    Agrelo R; Cheng WH; Setien F; Ropero S; Espada J; Fraga MF; Herranz M; Paz MF; Sanchez-Cespedes M; Artiga MJ; Guerrero D; Castells A; von Kobbe C; Bohr VA; Esteller M
    Proc Natl Acad Sci U S A; 2006 Jun; 103(23):8822-7. PubMed ID: 16723399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Camptothecin targets WRN protein: mechanism and relevance in clinical breast cancer.
    Shamanna RA; Lu H; Croteau DL; Arora A; Agarwal D; Ball G; Aleskandarany MA; Ellis IO; Pommier Y; Madhusudan S; Bohr VA
    Oncotarget; 2016 Mar; 7(12):13269-84. PubMed ID: 26959889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of CHFR Promoter Methylation with Treatment Outcomes of Irinotecan-Based Chemotherapy in Metastatic Colorectal Cancer.
    Cha Y; Kim SY; Yeo HY; Baek JY; Choi MK; Jung KH; Dong SM; Chang HJ
    Neoplasia; 2019 Jan; 21(1):146-155. PubMed ID: 30562637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weekly irinotecan in patients with metastatic gastric cancer failing cisplatin-based chemotherapy.
    Chun JH; Kim HK; Lee JS; Choi JY; Lee HG; Yoon SM; Choi IJ; Ryu KW; Kim YW; Bae JM
    Jpn J Clin Oncol; 2004 Jan; 34(1):8-13. PubMed ID: 15020657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WRN counteracts the NHEJ pathway upon camptothecin exposure.
    Otsuki M; Seki M; Kawabe Y; Inoue E; Dong YP; Abe T; Kato G; Yoshimura A; Tada S; Enomoto T
    Biochem Biophys Res Commun; 2007 Apr; 355(2):477-82. PubMed ID: 17303082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aging is accompanied by a progressive decrease of expression of the WRN gene in human blood mononuclear cells.
    Polosak J; Kurylowicz A; Roszkowska-Gancarz M; Owczarz M; Puzianowska-Kuznicka M
    J Gerontol A Biol Sci Med Sci; 2011 Jan; 66(1):19-25. PubMed ID: 20855428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of CHFR and MLH1 methylation in human gastric cancer.
    Li Y; Yang Y; Lu Y; Herman JG; Brock MV; Zhao P; Guo M
    Gastric Cancer; 2015 Apr; 18(2):280-7. PubMed ID: 24748501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Werner syndrome as a hereditary risk factor for exocrine pancreatic cancer: potential role of WRN in pancreatic tumorigenesis and patient-tailored therapy.
    Chun SG; Yee NS
    Cancer Biol Ther; 2010 Sep; 10(5):430-7. PubMed ID: 20657174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer and polymorphisms in DNA repair genes WRN, RMI1 and BLM.
    Frank B; Hoffmeister M; Klopp N; Illig T; Chang-Claude J; Brenner H
    Carcinogenesis; 2010 Mar; 31(3):442-5. PubMed ID: 19945966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms of the TP53 codon 72 and WRN codon 1367 in individuals from Northern Brazil with gastric adenocarcinoma.
    Khayat AS; Lobo Gatti L; Moura Lima E; de Assumpção PP; Nascimento Motta FJ; Harada ML; Casartelli C; Marques Payão SL; Cardoso Smith MA; Burbano RR
    Clin Exp Med; 2005 Dec; 5(4):161-8. PubMed ID: 16362795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of a camptothecin derivative, CPT-11, against human tumor xenografts in nude mice.
    Kawato Y; Furuta T; Aonuma M; Yasuoka M; Yokokura T; Matsumoto K
    Cancer Chemother Pharmacol; 1991; 28(3):192-8. PubMed ID: 1855276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Werner syndrome gene product helicase in carcinogenesis and in resistance to genotoxins by cancer cells.
    Futami K; Ishikawa Y; Goto M; Furuichi Y; Sugimoto M
    Cancer Sci; 2008 May; 99(5):843-8. PubMed ID: 18312465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.